FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131249092> ?p ?o ?g. }

• W2131249092 abstract "Abstract Background A subgroup has emerged within the obese that do not display the typical metabolic disorders associated with obesity and are hypothesized to have lower risk of complications. The purpose of this review was to analyze the literature which has examined the burden of cardiovascular disease (CVD) and all-cause mortality in the metabolically healthy obese (MHO) population. Methods Pubmed, Cochrane Library, and Web of Science were searched from their inception until December 2012. Studies were included which clearly defined the MHO group (using either insulin sensitivity and/or components of metabolic syndrome AND obesity) and its association with either all cause mortality, CVD mortality, incident CVD, and/or subclinical CVD. Results A total of 20 studies were identified; 15 cohort and 5 cross-sectional. Eight studies used the NCEP Adult Treatment Panel III definition of metabolic syndrome to define “metabolically healthy”, while another nine used insulin resistance. Seven studies assessed all-cause mortality, seven assessed CVD mortality, and nine assessed incident CVD. MHO was found to be significantly associated with all-cause mortality in two studies (30%), CVD mortality in one study (14%), and incident CVD in three studies (33%). Of the six studies which examined subclinical disease, four (67%) showed significantly higher mean common carotid artery intima media thickness (CCA-IMT), coronary artery calcium (CAC), or other subclinical CVD markers in the MHO as compared to their MHNW counterparts. Conclusions MHO is an important, emerging phenotype with a CVD risk between healthy, normal weight and unhealthy, obese individuals. Successful work towards a universally accepted definition of MHO would improve (and simplify) future studies and aid inter-study comparisons. Usefulness of a definition inclusive of insulin sensitivity and stricter criteria for metabolic syndrome components as well as the potential addition of markers of fatty liver and inflammation should be explored. Clinicians should be hesitant to reassure patients that the metabolically benign phenotype is safe, as increased risk cardiovascular disease and death have been shown." @default.
• W2131249092 created "2016-06-24" @default.
• W2131249092 creator A5003912464 @default.
• W2131249092 creator A5008531984 @default.
• W2131249092 creator A5012676647 @default.
• W2131249092 creator A5016564415 @default.
• W2131249092 creator A5019137371 @default.
• W2131249092 creator A5028595593 @default.
• W2131249092 creator A5049530348 @default.
• W2131249092 creator A5059011391 @default.
• W2131249092 creator A5059818287 @default.
• W2131249092 creator A5064295057 @default.
• W2131249092 creator A5078652439 @default.
• W2131249092 creator A5079665496 @default.
• W2131249092 creator A5080176676 @default.
• W2131249092 creator A5091313655 @default.
• W2131249092 date "2014-01-08" @default.
• W2131249092 modified "2023-10-01" @default.
• W2131249092 title "Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review" @default.
• W2131249092 cites W1506409364 @default.
• W2131249092 cites W1943273005 @default.
• W2131249092 cites W1969623610 @default.
• W2131249092 cites W1976025452 @default.
• W2131249092 cites W1987632608 @default.
• W2131249092 cites W1990781032 @default.
• W2131249092 cites W1992214056 @default.
• W2131249092 cites W2006862294 @default.
• W2131249092 cites W2008113677 @default.
• W2131249092 cites W2011921934 @default.
• W2131249092 cites W2031369558 @default.
• W2131249092 cites W2038288742 @default.
• W2131249092 cites W2044542930 @default.
• W2131249092 cites W2051443057 @default.
• W2131249092 cites W2065815699 @default.
• W2131249092 cites W2068889706 @default.
• W2131249092 cites W2077307748 @default.
• W2131249092 cites W2098059712 @default.
• W2131249092 cites W2098914554 @default.
• W2131249092 cites W2101099513 @default.
• W2131249092 cites W2102129701 @default.
• W2131249092 cites W2113318243 @default.
• W2131249092 cites W2114467602 @default.
• W2131249092 cites W2119609179 @default.
• W2131249092 cites W2120397203 @default.
• W2131249092 cites W2124576200 @default.
• W2131249092 cites W2128026698 @default.
• W2131249092 cites W2129413693 @default.
• W2131249092 cites W2131147285 @default.
• W2131249092 cites W2131879161 @default.
• W2131249092 cites W2134194392 @default.
• W2131249092 cites W2138885070 @default.
• W2131249092 cites W2141398296 @default.
• W2131249092 cites W2142052994 @default.
• W2131249092 cites W2146281387 @default.
• W2131249092 cites W2150345354 @default.
• W2131249092 cites W2153538485 @default.
• W2131249092 cites W2157882918 @default.
• W2131249092 cites W2158226607 @default.
• W2131249092 cites W2164418602 @default.
• W2131249092 cites W2167503069 @default.
• W2131249092 cites W2329017730 @default.
• W2131249092 doi "https://doi.org/10.1186/1471-2458-14-14" @default.
• W2131249092 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3890499" @default.
• W2131249092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24400816" @default.
• W2131249092 hasPublicationYear "2014" @default.
• W2131249092 type Work @default.
• W2131249092 sameAs 2131249092 @default.
• W2131249092 citedByCount "240" @default.
• W2131249092 countsByYear W21312490922014 @default.
• W2131249092 countsByYear W21312490922015 @default.
• W2131249092 countsByYear W21312490922016 @default.
• W2131249092 countsByYear W21312490922017 @default.
• W2131249092 countsByYear W21312490922018 @default.
• W2131249092 countsByYear W21312490922019 @default.
• W2131249092 countsByYear W21312490922020 @default.
• W2131249092 countsByYear W21312490922021 @default.
• W2131249092 countsByYear W21312490922022 @default.
• W2131249092 countsByYear W21312490922023 @default.
• W2131249092 crossrefType "journal-article" @default.
• W2131249092 hasAuthorship W2131249092A5003912464 @default.
• W2131249092 hasAuthorship W2131249092A5008531984 @default.
• W2131249092 hasAuthorship W2131249092A5012676647 @default.
• W2131249092 hasAuthorship W2131249092A5016564415 @default.
• W2131249092 hasAuthorship W2131249092A5019137371 @default.
• W2131249092 hasAuthorship W2131249092A5028595593 @default.
• W2131249092 hasAuthorship W2131249092A5049530348 @default.
• W2131249092 hasAuthorship W2131249092A5059011391 @default.
• W2131249092 hasAuthorship W2131249092A5059818287 @default.
• W2131249092 hasAuthorship W2131249092A5064295057 @default.
• W2131249092 hasAuthorship W2131249092A5078652439 @default.
• W2131249092 hasAuthorship W2131249092A5079665496 @default.
• W2131249092 hasAuthorship W2131249092A5080176676 @default.
• W2131249092 hasAuthorship W2131249092A5091313655 @default.
• W2131249092 hasBestOaLocation W21312490921 @default.
• W2131249092 hasConcept C107130276 @default.
• W2131249092 hasConcept C113280763 @default.
• W2131249092 hasConcept C126322002 @default.
• W2131249092 hasConcept C201903717 @default.
• W2131249092 hasConcept C2777391703 @default.
• W2131249092 hasConcept C2778213512 @default.

• next